ID 54456
Sort Key
5
Title Alternative
Identification of the adipokine ‘vaspin’ and its significance in metabolic syndrome
FullText URL
Thumnail 128_103.pdf 2.88 MB
Author
Wada, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Keywords
metabolic syndrome
adipokine
atherosclerosis
endothelial cells
apoptosis
Note
総説(Reviews)
Publication Title
Journal of Okayama Medical Association
Published Date
2016-08-01
Volume
volume128
Issue
issue2
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
103
End Page
109
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
isVersionOf https://doi.org/10.4044/joma.128.103
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2016 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma
References
1 ) Hida K, Wada J, Zhang H, Hiragushi K, Tsuchiyama Y, Shikata K, Makino H : Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. J Lipid Res (2000) 41, 1615-1622.
2 ) Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS : Visceral adipose tissue-derived serine protease inhibitor : a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A (2005) 102, 10610-10615.
3 ) Namciu SJ, Friedman RD, Marsden MD, Sarausad LM, Jasoni CL, Fournier RE : Sequence organization and matrix attachment regions of the human serine protease inhibitor gene cluster at 14q32.1. Mamm Genome (2004) 15, 162-178.
4 ) Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Horiguchi CS, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H : Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex. Diabetes (2012) 61, 2823-2832.
5 ) Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H : Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex. Circ Res (2013) 112, 771-780.
6 ) Quinones QJ, de Ridder GG, Pizzo SV : GRP78 : a chaperone with diverse roles beyond the endoplasmic reticulum. Histol Histopathol (2008) 23, 1409-1416.
7 ) Caminos JE, Bravo SB, Garces MF, Gonzalez CR, Cepeda LA, Gonzalez AC, Nogueiras R, Gallego R, Garcia-Caballero T, Cordido F, Lopez M, Dieguez C : Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status. Histol Histopathol (2009) 24, 979-990.
8 ) Fu BD, Yamawaki H, Okada M, Hara Y : Vaspin can not inhibit TNF-alpha-induced inflammation of human umbilical vein endothelial cells. J Vet Med Sci (2009) 71, 1201-1207.
9 ) Gonzalez-Gronow M, Kaczowka SJ, Payne S, Wang F, Gawdi G, Pizzo SV : Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel. J Biol Chem (2007) 282, 32811-32820.
10) Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Iseda I, Matsushita Y, Miyatake N, McDonald JF, Hotta K, Makino H : Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab (2012) 97, E1202-1207.
11) Kobat MA, Celik A, Balin M, Altas Y, Baydas A, Bulut M, Aydin S, Dagli N, Yavuzkir MF, Ilhan S : The investigation of serum vaspin level in atherosclerotic coronary artery disease. J Clin Med Res (2012) 4, 110-113.
12) Zhang B, Peng W, Li H, Lu Y, Zhuang J, Wang K, Su Y, Xu Y : Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions. Clin Biochem (2013) 46, 1520-1525.
13) Li HL, Peng WH, Cui ST, Lei H, Wei YD, Li WM, Xu YW : Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med (2011) 49, 1547-1554.
14) Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G, Lampropoulos S : Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta (2011) 412, 48-52.
15) Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, Park YJ, Jang HC, Kim MS : Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) (2011) 75, 628-635.
16) Esaki E, Adachi H, Hirai Y, Yamagishi S, Kakuma T, Enomoto M, Fukami A, Kumagai E, Ohbu K, Obuchi A, Yoshimura A, Nakamura S, Nohara Y, Fujiyama T, Fukumoto Y, Imaizumi T : Serum vaspin levels are positively associated with carotid atherosclerosis in a general population. Atherosclerosis (2014) 233, 248-252.
17) Li HL, Zhang HL, Jian WX, Li Q, Peng WH, Xu YW : Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study. Clin Chim Acta (2013) 415, 233-238.
18) Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM, Lee YL, Park JY : Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun (2011) 413, 264-269.
19) Jung CH, Lee WJ, Hwang JY, Lee MJ, Seol SM, Kim YM, Lee YL, Kim HS, Kim MS, Park JY : Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells. PLoS One (2012) 7, e52346.
20) Jung CH, Lee MJ, Kang YM, Lee YL, Yoon HK, Kang SW, Lee WJ, Park JY : Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovasc Diabetol (2014) 13, 41.
21) Li H, Peng W, Zhuang J, Lu Y, Jian W, Wei Y, Li W, Xu Y : Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-kappaB signaling pathways. Atherosclerosis (2013) 228, 61-68.
22) Phalitakul S, Okada M, Hara Y, Yamawaki H : A novel adipocytokine, vaspin inhibits platelet-derived growth factor-BB-induced migration of vascular smooth muscle cells. Biochem Biophys Res Commun (2012) 423, 844-849.
23) Phalitakul S, Okada M, Hara Y, Yamawaki H : Vaspin prevents TNF-alpha-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-kappaB and PKCtheta activation in cultured rat vascular smooth muscle cells. Pharmacol Res (2011)64, 493-500.
24) Kiskac M, Zorlu M, Akkoyunlu ME, Kilic E, Karatoprak C, Cakirca M, Yavuz E, Ardic C, Camli AA, Cikrikcioglu M, Kart L : Vaspin and lipocalin-2 levels in severe obsructive sleep apnea. J Thorac Dis (2014) 6, 720-725.